A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment

Inclusion Criteria: * Men with a tumour T1-3 stage prostate cancer and have had radical radiotherapy with curative intent * Are between six and twelve months post-treatment completion * Have completed all treatment for prostate cancer (including hormonal deprivation therapy) * Have no evidence of metastatic disease * ECOG performance status of between 0-1 * Remains willing to comply with study requirements * Has maintained contact with an individual general practitioner Exclusion Criteria: * Persistent complications resulting from treatment defined as a minimum Grade 3 treatment toxicity * Unable to complete self-administered questionnaires * Are currently enrolled in a study that requires specialist follow-up * Life expectancy of less than 6 months * Surgery to remove the prostate * Evidence of biochemical failure